RxDoctor Payments Data

Courtney Turk

Physician Assistant · Glassboro, NJNPI 1134152846

Payments from drug & device makers

$3,382in general payments, 2019–2025

Across 204 payments — averaging $16.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$752
  • AbbVie$420
  • AstraZeneca$369
  • GSK$353
  • Exact Sciences$286
  • Astellas Pharma US Inc$196
  • plus $1K from 21 others

What the payments were for

  • Food & beverage$3,382100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,382 in reported general payments places this provider in the 90th percentile of 2,726 physician assistant providers in New Jersey.

See all physician assistant providers in New Jersey

Medicare billing

Part B allowed, 2024
$42,436
Medicare patients
159
Services billed
484

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide30$28,733
WegovySemaglutide15$19,772
RybelsusSemaglutide11$14,042
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$13,044
Levothyroxine Sodium124$2,162
Atorvastatin Calcium186$1,955
SynthroidLevothyroxine Sodium20$1,583
Albuterol Sulfate HfaAlbuterol Sulfate36$1,511
Lisinopril157$1,267
Metoprolol Succinate77$1,184
Esomeprazole Magnesium27$979
Escitalopram Oxalate64$795
Duloxetine Hcl21$795
Losartan Potassium74$789
Omeprazole59$760

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Wegovy, Rybelsus$752$62,54756 claims
GSKTrelegy Ellipta$353$13,04420 claims
AbbVieSynthroid$420$1,58320 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,726 physician assistant providers in New Jersey.

Other physician assistant in Glassboro

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →